INTERfering and Co-Evolving Prevention and Therapy

Post Date

April 28th 2016

Application Due Date

July 7th 2016

4:00 PM ET

Funding Opportunity Number

DARPA-BAA-16-35

CFDA Number(s)

12.910

Funding Instrument Type(s)

Cooperative Agreement
Grant
Other

Funding Activity Categories

Science and Technology and other Research and Development

Eligibility Categories

Unrestricted

Funding

• Award Range:

  $None - $None

Grant Description

Under the INTERCEPT BAA-16-35, DARPA is soliciting innovative proposals for research to explore and develop therapeutic interfering particles as a novel approach to address infections from fast evolving viral pathogens.

Contact Information

• Agency

  Department of Defense

• Office:

  Defense Advanced Research Projects Agency

• Agency Contact:

  James Gimlett, Ph.D. Program Manager
  Biological Technologies Office (BTO)

• Agency Mailing Address:

  BAA Coordinator

• Agency Email Address:

  DARPA-BAA-16-35@darpa.mil

• Location:

  DARPA - Biological Technologies Office

• More Information:

  FBO Link